Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide

Abstract Venetoclax-based doublets with azacitidine or low dose cytarabine are the standard of care for the treatment of acute myeloid leukemia (AML) in older patients or those unfit for intensive chemotherapy. However, some patients do not attain complete remission, and over time, most patients rel...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Wei-Ying Jen, Curtis A. Lachowiez, Jennifer Marvin-Peek, Jessica K. Altman, Musa Yilmaz, Jacqueline S. Garcia, Yasmin Abaza, Nicholas J. Short, Joshua F. Zeidner, Naval G. Daver, Andrew H. Wei, Ghayas C. Issa, Courtney D. DiNardo
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Publishing Group 2025-11-01
Serier:	Blood Cancer Journal
Online adgang:	https://doi.org/10.1038/s41408-025-01429-z
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!